urÇmwGif a&yef;pm;vmaom tonf;a&m*g rsm;ESifh ywfoufí
jrefrmjynfoljynfom; rsm; BudKwif umuG,fwm;qD;Edkif&efESifh
a&m*g ukxHk;rsm;taMumif;udk &efukefaq;½kHBuD;?
tonf;a&m*gXmerS ygarmu© a'gufwm cifarmif0if;ESifh awGUqHkar;jref;cJhygonf/
|
ygarmu©a'gufwmcifarmif0if;
|
Ä ,ckvuf½SdrSm tonf;a&m*g
trsKd; tpm;ta&twGuf b,fESrsKd;avmuf½Sd ygovJ/
tckavmavmq,ftxdawmh ckepfrsKd; avmuf½Sdygw,f/ tonf;a&m*gydk;jzpfwJh
at? tD;eJY tufzfwdkU[m tpm;taomufeJU a&uae ul;pufEdkifNyD;
bD? pD? 'D? *sDwkdYu awmh aoG;oGif;wmwdkY ta&jym;udkxdk;
azmufNyD; aq;xdk;wmwdkY aq;rifaMumifxdk; wmwdkY? em;azmufwmwdkYtjyif
vdifqufqHrI wdkYaMumifhvnf; ul;pufEdkifygw,f/
Ä 'D ckepfrsKd;xJrSm b,fydk;u tul;puf
vG,fqHk;jzpfNyD; tonf;uifqma&m*g jzpfzdkY tvm;tvm t½SdqHk;jzpfrvJ/
tonf;a&miftom;0gbDydk;u tqdk;qHk; jzpfNyD; ul;pufwmvnf;
vsifjrefygw,f/ bDa&m*gydk;½Sdol[m tonf;uifqmjzpfzdkY
twGuf 295 qydkNyD; tcGifhtvrf;½Sdygw,f/ attdkif'Dtufpfydk;eJY
,SOfr,fqdk&if tq wpf&m ydkNyD;ul;vG,fygw,f/ bDydk;ygwJhaoG;
vufzuf&nfZGef; wpfZGef;rSm bDydk;a& ig;oef;cefYygEdkifNyD;
HIV/AIDS ydk;ygwJhaoG; vufzuf&nfZGef;rSmawmh HIV ydk;ig;aumif
yJ ygEdkifygw,f/
Ä bDydk;umuG,faq;b,fESrsKd; ½SdygovJ/
a&m*gjzpfwJhvl&JUaoG;&nfMunf Plasma
Derived umuG,faq;udk aq;okawoe rSmxkwfvkyfygw,f/ urÇmrSmawmh
Yeast u xkwfwJh
Genetically Engineered (Recombinant) udk toHk;rsm;Muygw,f/
Ä bDa&m*g r½SdwJh olwpfa,muf[m
umuG,faq; xdk;NyD;ayr,fh ay:vm wwfao;w,fqdkwm[kwfygovm;/
ay:wwfygw,f/ 'gayr,fh &mcdkifEIef; t&rf;enf;ygw,f/ aoG;uxkwfwhJhumuG,f
aq;jzpfwJhtwGuf Antigen
udk tylay;NyD; alumionium
hydroxide eJYaygif;&if umuG,faq;jzpfygw,f/ tJ'D antigen
udk cE¨mudk,fxJxdk;ay;&if a&m*gydk;udk wdkufzsuf
wJh
Anti body xGufvmygw,f/ 'gaMumifh wpfcgwav umuG,faq;xdk;NyD;vdkY
aoG; ppfMunfh&if bDydk;ay:aewm awGU&wwfyg w,f/ 'guvnf;
wpfywfftwGif;avmuf rSmygyJ/
HBsAg vdkYac:wJh bDydk;udkr,lbJ tcGHudkom,lNyD; a&m*gumuG,faq;xkwf
xm;wJhtwGuf umuG,faq;aMumihfawmh a&m*grjzpfEdkifygbl;/ aoG;uawmh
oefY& r,f/
Ä vlemawGuae wpfqifh ul;puffjcif;
cH&wJh q&m0eftwGuf b,fvdkukorI awGvkyfEdkifygovJ/
vlemudkaq;xdk;&if;? 'grSr[kwf cGJpdwf&if; eJY ul;pufjcif;cH&wJh
q&mawGtwGufu awmh passive immunisation
vdkYac:whJ hepatitis
B immune Globulin u a&m*gydk;udk wefjyefwdkufcdkufygw,f/
'Daq; u xdk;NyD; 15 rdepftwGif; a&m*gydk;udk wdkufzsufygw,f/
q&m0eftaeeJY a&m*g umuG,faq;udkvnf; xdk;xm;oifhygw,f/
Ä uav;eJYvlBuD;awGrSm tonf;a&mif
tom;0gbDydk;u b,fvdkul;pufjzpf yGm;ygovJ/
uav;i,fwpfOD; bDydk;ul;pufcH&&if 80 &mcdkifEIef;u
vHk;0emvefrxlawmhbJ emwm ½Snf ydk;o,faqmifol Chronic
Carrier jzpfoGm;ygw,f/ tJ'guawmh uav;&JU udk,fcHtm;u
vHk;0 r½SdvdkYygyJ/ vlBuD;u udk,fcHtm;½SdwJh twGuf
ydk;udk wefjyef wdkufcdkufEdkifygw,f/ vlBuD;rSm ul;puf&if
awmh 20 &mcdkifEIef;avmufyJ chronic
carrier jzpfEdkifygw,f/ 'gaMumifh uav;awGudk arG;NyD;NyD;csif;
12 em&DtwGif; umuG,f aq; xdk;ay;wm taumif;qHk;ygyJ/
Ä bDydk;ul;pufcH&wJh vlemwpfa,mufu
ol[m emwm½Snfydk;o,faqmifoljzpf rjzpfqdkwmb,fvdkodEdkifygovJ
q&m/
yxrtBudrf bDydk;½Sd r½Sdprf;oyf&ygw,f/prf;oyfNyD;aemuf
ajcmufvMumvdkY jyefprf; oyfwJhtcg ½Sdaeao;&if emwm½Snfydk;o,f
aqmifolvdkY owfrSwfEdkifygw,f/
Ä bDydk;ul;pufrIudk b,fvdk umuG,f
EdkifygovJ/
umuG,frIuawmh usef;rma&; 0efxrf; awGuaewpfqifhp&rSmyg/
vlemwpfa,muf uae wpfa,muf rul;&atmif wpfcgoHk; aq;xdk;tyfwdkY?
omrdkrDwmwdkY oHk;oifhyg w,f/ wpfcgoHk; roHk;Edkif&ifvnf;
toHk;jyK r,fhud&d,mwefqmyvmawGudk a&aEG;eJY owfrSwfxm;wJhtylcsdefrSm
xm;NyD; aygif;cH oefYpif&ygr,f/ a&m*gydk;½SdwJh
vlemudk udkifwG,fprf;oyfwJhtcgrSm q&m0efu vuftdwf 0wfxm;oifhovdk
vlemprf;wJh tdyfpifrSmvnf; wpfcgoHk;t0wfjzpfjzpf? puúLyJjzpfjzpf
cif;xm;oifhygw,f/ vlem wpfa,muf tdyfvdkuf aemufwpfa,muf prf;oyfzdkY
tdyfvdkufeJY a&m*gul;pufzdkYtcGifh tvrf;rsm;ygw,f/
vlxkynmay;taeeJY uawmh qGrf;auR; wJhtvSLawGrSm [if;csKdyef;uef
wpfvHk; wnf;xm;r,fhtpm; wpfa,mufudk [if;csKd yef;uefvHk;wpfvHk;pD
xm;ay;&if [if;csKd aomufwJh ZGef;uae a&m*gul;pufrIukd
wm;qD;EdkifrSm jzpfygw,f/ vdifqufqHrI uaevnf; ul;pufEdkifwJhtwGuf
vHkNcHK pdwfcswJh tumtuG,fypönf; (uGef'Hk;)udk oHk;oifhygw,f/
Ä bDydk;ul;pufNyD;wJholua&m
a&m*gtajc taerqdk;atmif b,fvdkaexdkif oifhyg ovJ/
aq;vdyf? t&uf? bD,m pwmawGudk a½Smif&rSmjzpfwJhtjyif
oH"mwfrsm;wJh tpm; tpmjzpfwJh aoG;cJ? tonf;tjrpf? uvDpm
eJY oH"mwfygwJh tm;aq;awGudkyg a½Smif&rSm jzpfygw,f/
a[mfrkef;"mwfudka½SmifEdkif&if vnf; aumif;ygw,f/
qdk;aq;eJY qdk;xm;wJh tpm;tpmawGudkvnf; vHk;0a½Smif&ygr,f/
Ä bDydk;uae wpfqifh jzpfyGm;wwfwJh
tonf;ajcmufa&m*g ½Sd r½Sdudka&m b,fvdkodEdkifygovJ/
tonf;tm;enf;wmudkawmh aoG;udk ppfaq;NyD;
Liver function Test (LFT) vkyfNyD; odEdkifygw,f/ tonf;ajcmufw,f?
usKHU w,f? jyKyfawGxaew,fqdk&ifawmh
Ultrasound eJU CT scan ½kdufMunfhvdkY odEdkifyg
w,f/ a&m*g tajctaeqdk;ae&if vufeJU udkifNyD;prf;oyf&ifawmifrS
odEdkifygw,f/
Ä tonf;a&miftom;0g bDydk; owf
aq;awGtaMumif;½Sif;jyay;ygOD;q&m/
wpfywf oHk;BudrfeJY ajcmufv xdk;&wJh tifwmz½Gefxdk;aq;
½Sdygw,f/ 'Dxdk;aq; twGuf ukefusp&dwfu odef;oHk;q,f0ef;
usif ½Sdygw,f/ vmrDAsL'if;pm;aq;eJU odkifrdk pifxdk;aq;wdkUvnf;
½Sdygw,f/ vmrDAsL'if; u aomufaq;jzpfvdkY aomuff&wmvG,ful
NyD; tifwmz½Gefxufvnf; tukeftus oufomygw,f/
Ä tonf;a&m*gpDydk;twGufa&m
umuG,f aq;½Sdygovm;/
tckxufxdawmh pDydk;umuG,faq; r½Sd ao;ygbl;/ 'gaMumifh
aoG;roGif;cifrSm aoG; udk aocsmppfoifhygw,f/ wpfpHkwpfckjzpf&if
vlemyJcH&rSmrdkY aoG;oGif;wJhudpöawGrSm txl; yJ *½kpdkufoifhygw,f/
Ä pDa&m*gydk; ul;pufNyD;olawG[m
b,f tcsdefus&if tonf;ajcmufa&m*g jzpf wwfygovJ/
pDydk;½SdolwpfOD;[m tESpf20 uae 25 ESpftwGif;rSm tonf;ajcmuf?
'grSr[kwf tonf;uifqmwdkY jzpfEdkifygw,f/
Ä pDydk;aysmufuif;atmif b,fvdkukxHk;
awG ½SdygovJ/
ukorIudk rcH,lcifrSm aoG;xJrSm pDydk; yg0ifEIef;jzpfwJh Viral
load vdkUac:wJh RNA
udkprf;&ygr,f/ NyD;&if Genotype
vdkY ac:wJh pDydk;trsKd;tpm;udk ppf&ygr,f/
Ä
Genotype b,fESpfrsKd;½SdygovJ/
Genotype
1 uae 6 txd ½Sdygw,f/ 'DxJrSm 2 eJU 3 u odyfrqdk;ygbl;/
tifwm z½Gefxdk;aq;udk wpfywf oHk;BudrfeJY tenf; qHk;
ajcmufvxdk;&ygr,f/ wjcm;
Genotype trsKd;tpm;awGudkawmh yuftifwm z½Gef xdk;aq;udk
&DbmAD&ifaomufaq;eJY wGJNyD; wpfywfwpfcgoHk;pGJ&ygr,f/xdk;aq;
wpfvHk; u usyfav;odef;ukefuswJhtwGuf ukefus p&dwfawmh rsm;ygw,f/
Ä 'Dvdk ukorIawG cH,l&ifa&m
a&m*g aysmufuif;Edkifygovm;/
80 &mcdkifEIef;u aocsmygw,f/ ukefus p&dwfrsm;wJhtwGuf
tukefcHEdkifr,fqdk&if awmh aysmufuif;Edkifygw,f/
Ä pDydk;eJYywfoufNyD; jynfolvlxktaeeJU
A[kokwa&m ½Sdygovm;/
vlxk&JU toduawmh tm;enf;aeyg w,f/ odoifhwJhtcsufuawmh tonf;
uifqmjzpfyGm;rI&JU 50 &mcdkifEIef;u pDydk; aMumifh qdkwmygyJ/
vlxku pDydk;xuf bDydk; taMumif;udk ydkNyD; odem;vnfMuygw,f/pDydk;ul;puf&if
80 &mcdkifEIef;u rvGJraoG tonf;ajcmufa&m*gjzpfrSm jzpfygw,f/aiGtukeftusrcHEdkifwJhvlemawGtwGuf
ao'PfcsrSwfxm;ovdk jzpfwmaMumifh rjzpfatmifBudKwifumuG,foifhygw,f/
|